Some of the stocks that may grab investor focus today are:
- Wall Street expects Bristol-Myers Squibb Co (NYSE:BMY) to report quarterly earnings at $1.48 per share on revenue of $9.97 billion before the opening bell. Bristol-Myers Squibb shares gained 4% to $62.10 in after-hours trading on an unconfirmed court document showing Sigmapharm NDA products infringe upon asserted claims of Bristol/Pfizer '208 patent.
- Analysts are expecting Cardinal Health Inc (NYSE:CAH) to have earned $0.92 per share on revenue of $36.67 billion for the latest quarter. Cardinal Health will release earnings before the opening bell. Cardinal Health shares gained 2.4% to $59.00 in after-hours trading.
- Roku Inc (NASDAQ:ROKU) posted stronger-than-expected results for its second quarter. The company added 3.2 million incremental active accounts in Q2. Roku shares fell 5% to $157.20 in the after-hours trading session.
- Before the markets open, ViacomCBS Inc. (NASDAQ:VIAC) is projected to report quarterly earnings at $0.93 per share on revenue of $6.17 billion. ViacomCBS shares gained 0.5% to $26.14 in after-hours trading.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Choosing the best broker is an important part of being a successful trader or investor
- Western Digital Corp (NASDAQ:WDC) reported upbeat earnings for its fiscal fourth quarter, while sales exceeded estimates. The company also issued downbeat EPS and sales guidance for the current quarter. Western Digital shares dropped 11.7% to $39.25 in the after-hours trading session.
- Analysts expect Uber Technologies Inc (NYSE:UBER) to post a quarterly loss at $0.86 per share on revenue of $2.18 billion after the closing bell. Uber shares rose 1.2% to $33.59 in after-hours trading.
- Metlife Inc (NYSE:MET) reported weaker-than-expected profit for its second quarter on Wednesday. Metlife shares declined 4.7% to $36.50 in the after-hours trading session.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.